Vectura Group Share Price (VEC)

172.50 +1.50 (+0.88%) delayed: 7:51PM BST
Bid price 172.00 Open price 169.75
Ask price 173.00 Prev close 173.00
High price 174.75 Spread 0.58%
Low price 169.19 Volume 1,025,823

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index n/a

Vectura Group Key Numbers

Latest Share Price (p) 172.50 Net Gearing (%) -6.27
Market Capitalisation (£m) 691.72 Gross Gearing (%) 24.40
Shares in issue (m) 404.52 Debt Ratio 10.20
P/E Ratio 190.00 Debt-to-Equity Ratio 0.35
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.32
Dividend Yield (%) 0.00 Price to book value 3.12
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) 0.90 EPS Growth (%) 228.57
52 week high / low 171.00 / 113.75 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
17/04/2015 EXR Dr Christopher Blackwell CEO 18,987
16/01/2015 EXR Dr Trevor Phillips ED 3,133
16/01/2015 EXR Dr Trevor Phillips ED 208,877
16/01/2015 SEXR Dr Trevor Phillips ED 171,777
08/07/2014 BUY Dr Christopher Blackwell CEO 1,212

More Vectura Group Director Deals >>

Vectura Group Company News

09:24 20/05/2015

Vectura widens FY pretax loss

Vectura Group has issued its preliminary results for the year ended 31 March 2015. It described the year as transformational. Its FY pretax loss came in at £6.2m, from a loss of £4.8m. Revenue was £58.0m, from £36.5m. At 9:24am: (LON:VEC) Vectura Group PLC share price was +1p at 164.25p...

07:23 20/05/2015

FLASH: Vectura widens FY pretax loss

Story provided by

07:00 20/05/2015

Preliminary Results

/* */ RNS Number : 7122N Vectura Group plc 20 May 2015     Vectura Group plc - Preliminary Results   Transformational Year - Maiden Profit Chippenham, UK - 20 May 2015: Vectura Group plc (LSE: VEC) ("Vectura"), which specialises in the...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

2 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions